Diagnosis and therapy of Anxiety Disorders

Authors

Keywords:

underdiagnosis, fear, anxiety, pharmacology

Abstract

The essential characteristics of anxiety disorders are excessive and persistent fear of situations that are misinterpreted as threatening, as well as mechanisms for avoiding perceived threats. Such disorders are one of the main causes of disability around the world, causing great suffering for patients and their families. In adulthood, anxiety disorders can be subdivided into: Specific Phobia, Social Anxiety Disorder, Panic Disorder, Agoraphobia, Generalized Anxiety Disorder. Treatment of these disorders should be done with a combination of psychotherapy and pharmacotherapy. However, the vast majority of individuals with an anxiety disorder remain untreated by professionals in health systems, due to the low rates of detection of these conditions.

Author Biographies

Laiana A. Quagliato, Universidade Federal do Rio de Janeiro (UFRJ)

Laboratório de Pânico e Respiração. Instituto de Psiquiatria – Universidade Federal do Rio de Janeiro - UFRJ

Antonio E. Nardi, Universidade Federal do Rio de Janeiro (UFRJ)

Laboratório de Pânico e Respiração. Instituto de Psiquiatria – Universidade Federal do Rio de Janeiro - UFRJ.

References

Russell JA. A circumplex model of affect. Journal of personality and social psychology 39, 1161 (1980).

Nardi AE, Fontenelle LF. & Crippa JAS. New trends in anxiety disorders. Brazilian Journal of Psychiatry 34, 5-6 (2012).

Davis M. et al. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 35, 105 (2010).

APA. Diagnostic and statistical manual of mental disorders: DSM-5TM, 5th ed. Arlington, VA, US: American Psychiatric Publishing, Inc.; 2013.

Beesdo K, Knappe S. & Pine DS. Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM‑V. Psychiatry Clinical North America 32, 483–524 (2009).

Freeston MH, Rhéaume J, Letarte H, Dugas MJ, Ladouceur R. Why do people worry? Personality and individual differences.17(6):791-802 (1994).

Roy‑Byrne PP. et al. Anxiety disorders and comorbid medical illness. General Hospital Psychiatry 30, 208–225 (2008).

Johansen JP, Hamanaka H, Monfils MH, Behnia R, Deisseroth K, Blair HT, et al. Optical activation of lateral amygdala pyramidal cells instructs associative fear learning. Proceedings of the National Academy of Sciences.107(28):12692-7 (2010).

Ciocchi S, Herry C, Grenier F, Wolff SB, Letzkus JJ, Vlachos I, et al. Encoding of conditioned fear in central amygdala inhibitory circuits. Nature. 468(7321):277 (2010).

Cai H, Haubensak W, Anthony TE, Anderson DJ. Central amygdala PKC-δ+ neurons mediate the influence of multiple anorexigenic signals. Nature neuroscience. 17(9):1240 (2014).

Haubensak W, Kunwar PS, Cai H, Ciocchi S, Wall NR, Ponnusamy R, et al. Genetic dissection of an amygdala microcircuit that gates conditioned fear. Nature. 468(7321):270 (2010).

Li H, Penzo MA, Taniguchi H, Kopec CD, Huang ZJ, Li B. Experience-dependent modification of a central amygdala fear circuit. Nature neuroscience. 16(3):332 (2013).

Penzo MA, Robert V, Li B. Fear conditioning potentiates synaptic transmission onto long-range projection neurons in the lateral subdivision of central amygdala. Journal of Neuroscience. 34(7):2432-7 (2014).

Penzo MA, Robert V, Tucciarone J, De Bundel D, Wang M, Van Aelst L, et al. The paraventricular thalamus controls a central amygdala fear circuit. Nature. 519(7544):455 (2015).

Cullinan WE, Herman JP, Watson SJ. Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. Journal of Comparative Neurology. 332(1):1-20 (1993).

Dong H-W, Petrovich GD, Swanson LW. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain research reviews. 38(1-2):192-246 (2001).

Baldwin DS et al. Evidence‑based pharmacological treatment of anxiety disorders, post‑traumatic stress disorder and obsessive‑compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. Journal of Psychopharmacology. 28, 403–439 (2014).

Quagliato LA et al. Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: a meta-analysis of common side effects in acute treatment. Journal of Psychopharmacology, 33(11), 1340-1351 (2019).

Published

2022-04-16

Issue

Section

Review articles